BackGT Biopharma Overview

GT Biopharma Other Current Assets

Latest other current assets for GTBP: $0.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$0.00
100.00% YoYΔ $-1.90M vs prior year quarter

Peer average / median

Loading

GT Biopharma Other Current Assets History

Loading

GT Biopharma vs. peers: Other Current Assets Comparison

Loading

GT Biopharma Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

GT Biopharma (GTBP) FAQ

As of the most recent data (June 2026), GTBP shows a other current assets of $0. That compares with $1.9M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GTBP's other current assets is now $0 (was $1.9M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether GT Biopharma is outperforming or lagging.

Tracking GTBP's other current assets over time shows whether GT Biopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $1.9M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has GT Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $0) with ownership activity and broader fundamentals.

GT Biopharma's other current assets is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.